Navigation Links
Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011
Date:8/23/2010

SAN DIEGO, Aug. 23 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today that based on solid bookings and sales activities in July and the first half of August that it expects its net sales for its second quarter of fiscal 2011 ending September 30, 2010, to be from $2.8 to $3.2 million, an increase of 158% to 195% compared to the first quarter of fiscal 2011 and 47% to 68% compared to the second quarter of the previous fiscal year.

"The first two months of our September ending quarter have progressed nicely as a result of shipments and bookings of our branded products in the mass market, Celadrin® and BioGuard®.  In addition BioGuard® is scheduled to be introduced at a major drug chain expanding its outreach beyond club stores," said William Spencer, Imagenetix's President and CEO. "We are not currently providing guidance on income, but expect with the significant increase in net sales that we will return to profitability.  We continue to see excellent acceptance of our products and believe we are positioned well for future revenue gains."

Cautionary Statement:The statements in this release relating to our guidance for net sales, profitability, and our being positioned for future revenue gains are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause our actual results to differ materially, including, but not limited to: the strength of the economic recovery or any further weakness or unexpected fluctuations in the U.S. or global economies; changes in demand or market acceptance of our products and the products of our customers; the mix of inventory we hold and our ability to satisfy short-term orders from our inventory; changes in utilization of our manufacturing capacity and our ability to effectively ramp our production levels; competitive developments including pricing pressures; the level of orders that are received and can be shipped in a quarter; the level of sell-through of our products through distribution; changes or fluctuations in customer order patterns and seasonality; disruptions in our business or the businesses of our customers or suppliers due to natural disasters, terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns or disruptions in the transportation system; and general economic, industry or political conditions in the United States or internationally.

For a detailed discussion of these and other risk factors, please refer to Imagenetix's filings on Forms 10-K and 10-Q. You can obtain copies of Forms 10-K and 10-Q and other relevant documents for free at the SEC's Web site (www.sec.gov) or from commercial document retrieval services.

Stockholders of Imagenetix are cautioned not to place undue reliance on our forward-looking statements, which speak only as of the date such statements are made. Imagenetix does not undertake any obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after this August 23, 2010 press release, or to reflect the occurrence of unanticipated events.

About ImagenetixImagenetix, based in San Diego, California, is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis.  Imagenetix develops and formulates propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution.  In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners.  Imagenetix is the creator of Celadrin®.  Please visit, www.celadrin.com, www.bioguardhealth.com or www.imagenetix.net. ContactImagenetix Investor Relations

William P. Spencer(858)385-2797

Chief Executive OfficerImagenetix, Inc.Tel: (858) 674-8455
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
2. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
3. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
4. PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
5. New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
6. China Nepstar Chain Drugstore Provides Updates on Shoppers Card Program
7. Newly Published Data Demonstrate ASP EVOTECH® ECR Provides Cleaning That is Superior to Manual Cleaning of Flexible Endoscopes
8. Mindray Medical Provides Mid-Year Update on Product Development
9. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
10. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
11. Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... 2017  Amy Baxter MD, chief executive officer and ... pain relief, was awarded a 2017 Top 40 Healthcare ... recognized at the MM&M Top 40 Healthcare Transformers dinner ... on May 10, 2017. The dinner followed a ... "beyond the pill."  "Innovation goes beyond invention," ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
Breaking Medicine Technology:
(Date:5/23/2017)... NY (PRWEB) , ... May 23, 2017 , ... ... in the pharmaceutical and medical device sectors, today announced the winners of its ... • Entrepreneurs) represent the most influential people in the healthcare industry today. , ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: Walter Schindler, ... this month as a Guest Speaker and Contributor to a weeklong series of classes, ... Purpose. , Walter Schindler and SAIL Capital have received ...
(Date:5/23/2017)... ... 2017 , ... Diagnotes, an Indianapolis-based digital healthcare communication company, ... secure clinical communication platform. The platform allows clinicians to easily escalate their preferred ... urgency of a situation. , “We know from our daily lives that ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... Therachat ... its new survey in an infographic on the current state of anxiety in support ... familiar with anxiety, was conducted in April 2017 and benchmarked general anxiety levels as ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Today, Our ... Washington, MO with a public ribbon cutting ceremony. Since opening over a ... an alternative to the emergency room. The new Our Urgent Care walk-in clinic ...
Breaking Medicine News(10 mins):